Navigation Links
New Nasal Drug Delivery Device for Chronic Sinusitis Patients Now Available from ASL Pharmacy
Date:5/4/2010

A new double barrel atomization device from ASL Pharmacy® offers hope for chronic sinusitis patients. The NasoNeb™ Nasal Nebulizer may be used for the administration of compounded tobramycin, clarithromycin, mupirocin, meropenem and other antibiotics, anti-fungals, mucolytics and corticosteroids.

Camarillo, CA (PRWEB) May 4, 2010 -- Chronic sinusitis patients have new hope for treatment with the release of a new drug delivery device from ASL Pharmacy®. Designed to administer compounded clarithromycin, liquid mupirocin, tobramycin, vancomycin, meropenem and other medications, the NasoNeb™ Nasal Nebulizer, manufactured by MedInvent, LLC, delivers a topical treatment by applying positive-pressure atomization towards the sinuses. The NasoNeb™ Nasal Nebulizer, an FDA listed medical device for nasal drug administration, utilizes the latest irrigation and atomization technologies to provide dual-nostril, positive-pressure medication deposition in less than two minutes, with minimal drug waste.

The device creates a low-volume irrigation effect with particles small enough to deposit medication to the right places, yet large enough to not enter the lungs or bronchioles. The NasoNeb™ Nasal Nebulizer may be prescribed by physicians when oral medications have failed or for patients who cannot tolerate oral medications.

"Patient compliance has been very high with this new device due to the short treatment time of only two minutes," states Russell Reitz, Pharm.D., Pharmacy Director for ASL®. "We have dispensed over 1,500 NasoNebs™ to patients thus far who are experiencing positive effects."

The NasoNeb™ Nasal Nebulizer allows the physician to efficiently perform maximal medical therapy on their patient. Recognizing new developments in medical therapy for chronic sinusitis, ASL® prepares and dispenses specialized compounded medications upon physician order to assist them in the management of difficult patient cases.

In the past when medications were combined, treatment time would also increase, meaning a patient could experience a 20-30 minute treatment. By combining the latest atomization and irrigation technologies, with the NasoNeb™, up to four medications may be mixed and administered in less than two minutes, something never before accomplished with a nasal nebulizer.

Sinus infections and allergies are common. It is estimated that 10 percent of the U.S. population (30 million-plus) suffer from chronic sinusitis caused by fungus, bacteria and/or allergens. About 400,000 of these patients receive sinus surgery for this disease annually. For many, chronic sinusitis is a debilitating, long-lasting experience. ASL Pharmacy's goal is to provide unique topical therapies not available commercially anywhere else with minimum bioavailability that assist physicians in managing sinus disease and help them improve each patient's quality of life.

"I have been having chronic sinus trouble for about 15 years," says one patient. "I have had surgery to remove nasal polyps six times. I typically get sinus infections about once a month. It seems I barely get done with an antibiotic before another infection sets in. I started using the NasoNeb™ system about six months ago. In that time, I have only had one sinus infection. And the NasoNeb™ took care of it before it got very bad. My sinus polyps have been reduced in size, and I am hopeful that I will not need any more surgeries. I would highly recommend this system to anyone who suffers with chronic sinus problems."

The dual-nostril, positive-pressure effect produced by the NasoNeb™ Nasal Nebulizer is similar to irrigation. An additional topical sinus therapy ASL® supports is sinus irrigations with the NeilMed® Sinus Rinse bottle, which is a single-nostril, positive-pressure device. The main difference between the squeeze bottle approach and the NasoNeb™ Nasal Nebulizer is that the NasoNeb™ atomizes low-volume saline and medications whereas the NeilMed® simply relies on liquid. All devices dispensed by ASL Pharmacy® are fast and easy. For topical sinus administration, ASL Pharmacy® only dispenses approved medical devices along with easy-to-use, pre-mixed, unit-dosed medication vials.

Another patient says: "I have had nasal and sinus problems for my entire life. I have used multiple antibiotics, nasal sprays, nebulizers, antihistamines, allergy therapy, decongestants and I have had five sinus surgeries…After three weeks on the NasoNeb™ with mometasone, I am 100 percent improved!"

ASL® focuses on preparing specialized compounds for the treatment of chronic sinusitis. Working with ENTs, allergists and other physicians who treat CRS, ASL® has helped more than 15,000 patients to date and is working with more than 1,800 physicians nationwide. The physician simply faxes his/her prescription to ASL® and ASL® does the rest. The patient's insurance is billed and the medications and devices ordered are then shipped directly to the patient's home. ASL® also provides patient education, which increases patient compliance. Given the enormous size of this patient population, ASL® has only scratched the surface in assisting physicians with treating chronic sinus disease. Therefore, ASL® is seeking additional physicians to help serve the larger population with chronic sinusitis.

Aerosol Science® Laboratories, Inc. dba ASL Pharmacy® is a privately held corporation with principal offices in Camarillo, CA.

Disclaimer: The NasoNeb™ Nasal Nebulizer is designed for use by a single person and is not to be shared with others, which could spread an infection. Close supervision is necessary when using a nebulizer on or near children or invalids. Safety instructions must be followed including not using this system in the presence of any flammable anesthetic mixture with air or with oxygen or nitrous oxide. The NasoNeb™ Nasal Nebulizer is available by prescription only.

For more information about the NasoNeb™ Nasal Nebulizer for the application of clarithromycin, liquid mupirocin, meropenem and other medications to chronic sinusitis sufferers, visit more Info.

Please direct all press inquiries to:
Cal Tarrant
805-482-5555 x300

# # #

Read the full story at http://www.prweb.com/releases/chronic_sinusitis/clarithromycin/prweb3917844.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Olympian Credits Sinus Buster Nasal Spray As Helping Her Get To Vancouver
2. Synthetic, dissolving plates ease repairs of nasal septum defects
3. Nearly 5 Million Doses of Nasal Swine Flu Vaccine Recalled
4. Proton beam therapy shows encouraging long-term outcome for patients with locally advanced sinonasal cancers
5. TechWorld Medicals NasalCare Nasal Cleanse Kit Named “Best New Product” at ECRM Cough & Cold and Allergy Conference
6. Nasal Irrigation for Treatment of Chronic and Acute Sinusitis and Rhinitis
7. Sinus Dynamics Reaches Milestone with Treatment of Nasal Allergy, Sinus Infection, Acute and Chronic Sinusitis Treating 25,000th Patient
8. Nasal Saline Rinses Reduce Ear Infections in Kids
9. Natural Delivery OK in Cases of Intrauterine Growth Restriction
10. PATH commends the Gates Foundation for their new commitment to fund vaccine innovation and delivery
11. Researchers develop new tool for gene delivery
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Nasal Drug Delivery Device for Chronic Sinusitis Patients Now Available from ASL Pharmacy 
(Date:12/9/2016)... Woodland Hills, CA (PRWEB) , ... December 09, ... ... center for young adults, celebrated its 10th anniversary with the grand opening of ... Hills, California. The successful event spanned two days, December 2-3, and was attended ...
(Date:12/9/2016)... NJ (PRWEB) , ... December 09, 2016 , ... ... Founders Ball at The Pierre Hotel in New York, NY, on December 3rd, ... benefactors, dignitaries and physicians attended the annual event, which raised over $1 million ...
(Date:12/9/2016)... ... December 09, 2016 , ... The Pennsylvania Athletic ... (PCN) during the summer of 2016. The program was made possible by a ... States Department of Health and Human Services Administration. The broadcast, Use Your ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Research Institute (WCRI) officially opened registration today for its 33rd Annual Issues ... Boston, MA . , The theme of the conference is “Persistent Challenges and ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Chester County, a Property owned by an affiliate of Seavest, has won a ... Penn Medicine Southern Chester County ambulatory care center (ACC) was named “Best New ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 Australia Glaucoma ... GlobalData,s new report, "Australia Glaucoma Surgery Devices ... on the Australia Glaucoma Surgery Devices market. The ... volume (in units) and average prices (USD) within ... report also provides company shares and distribution shares ...
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... poised to grow in 2017-2023. Various reasons for growth ... obese population, higher incidences of chronic diseases, high recovery ... mobility aid services. Medical lifting sling refers to ... with limited mobility. These slings connect to the lift ...
(Date:12/8/2016)... INDIANAPOLIS , Dec. 8, 2016  Eli Lilly ... detailed results of its phase 3 EXPEDITION3 trial at ... (CTAD) meeting. As previously disclosed, solanezumab did not meet ... study of solanezumab initiated in people with mild dementia ... pursue regulatory submissions for solanezumab for the treatment of ...
Breaking Medicine Technology: